These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 11159537
1. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik M, Billestrup N, Odum N. Blood; 2001 Feb 15; 97(4):1056-62. PubMed ID: 11159537 [Abstract] [Full Text] [Related]
2. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Leukemia; 2001 May 15; 15(5):787-93. PubMed ID: 11368440 [Abstract] [Full Text] [Related]
3. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. Ding Y, Chen D, Tarcsafalvi A, Su R, Qin L, Bromberg JS. J Immunol; 2003 Feb 01; 170(3):1383-91. PubMed ID: 12538698 [Abstract] [Full Text] [Related]
4. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling. Kim H, Suh JM, Hwang ES, Kim DW, Chung HK, Song JH, Hwang JH, Park KC, Ro HK, Jo EK, Chang JS, Lee TH, Lee MS, Kohn LD, Shong M. J Immunol; 2003 Jul 15; 171(2):616-27. PubMed ID: 12847226 [Abstract] [Full Text] [Related]
5. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Nielsen M, Kaltoft K, Nordahl M, Röpke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N. Proc Natl Acad Sci U S A; 1997 Jun 24; 94(13):6764-9. PubMed ID: 9192639 [Abstract] [Full Text] [Related]
6. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation. Wu J, Nihal M, Siddiqui J, Vonderheid EC, Wood GS. J Invest Dermatol; 2009 May 24; 129(5):1165-73. PubMed ID: 18923451 [Abstract] [Full Text] [Related]
7. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C. Radaeva S, Jaruga B, Kim WH, Heller T, Liang TJ, Gao B. Biochem J; 2004 Apr 01; 379(Pt 1):199-208. PubMed ID: 14690454 [Abstract] [Full Text] [Related]
8. Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma. Dummer R, Sigg-Zemann S, Kalthof K, Muletta S, Meyer JC, Burg G. Dermatology; 1994 Apr 01; 189(2):120-4. PubMed ID: 7915555 [Abstract] [Full Text] [Related]
9. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C, Wasik M, Ødum N. Leukemia; 2005 Feb 01; 19(2):209-13. PubMed ID: 15618960 [Abstract] [Full Text] [Related]
10. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C, Eriksen KW, Woetmann A, Kaestel CG, Nissen MH, Ropke C, Skov S, Ødum N. Leukemia; 2004 Jul 01; 18(7):1288-95. PubMed ID: 15141228 [Abstract] [Full Text] [Related]
11. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F. J Immunol; 2002 Jun 15; 168(12):6404-11. PubMed ID: 12055259 [Abstract] [Full Text] [Related]
12. SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells. Lundin Brockdorff J, Woetmann A, Mustelin T, Kaltoft K, Zhang Q, Wasik MA, Röpke C, Ødum N. Cytokine; 2002 Nov 24; 20(4):141-7. PubMed ID: 12543077 [Abstract] [Full Text] [Related]
13. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. Park ES, Kim H, Suh JM, Park SJ, Kwon OY, Kim YK, Ro HK, Cho BY, Chung J, Shong M. Mol Endocrinol; 2000 Mar 24; 14(3):440-8. PubMed ID: 10707961 [Abstract] [Full Text] [Related]
15. Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3. Nielsen M, Nissen MH, Gerwien J, Zocca MB, Rasmussen HM, Nakajima K, Röpke C, Geisler C, Kaltoft K, Ødum N. Blood; 2002 Feb 01; 99(3):973-7. PubMed ID: 11807001 [Abstract] [Full Text] [Related]
16. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). Bunn PA, Foss FM. J Cell Biochem Suppl; 1996 Feb 01; 24():12-23. PubMed ID: 8806090 [Abstract] [Full Text] [Related]
17. Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3. Wu X, Herndon DN, Wolf SE. Shock; 2003 Apr 01; 19(4):314-20. PubMed ID: 12688541 [Abstract] [Full Text] [Related]
18. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. Lejeune D, Demoulin JB, Renauld JC. Biochem J; 2001 Jan 01; 353(Pt 1):109-116. PubMed ID: 11115404 [Abstract] [Full Text] [Related]
19. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C. J Immunol; 2002 Jul 01; 169(1):434-42. PubMed ID: 12077274 [Abstract] [Full Text] [Related]
20. Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells. Sakai I, Takeuchi K, Yamauchi H, Narumi H, Fujita S. Blood; 2002 Oct 15; 100(8):2926-31. PubMed ID: 12351404 [Abstract] [Full Text] [Related] Page: [Next] [New Search]